Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 848 entries
Sorted by: Best Match Show Resources per page
Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients.

Radiology and oncology

Hribernik A, Cemazar M, Sersa G, Bosnjak M, Snoj M.
PMID: 27069446
Radiol Oncol. 2016 Feb 16;50(1):21-7. doi: 10.1515/raon-2015-0048. eCollection 2016 Mar 01.

BACKGROUND: The combination of electrochemotherapy with immuno-modulatory treatments has already been explored and proven effective. However, the role of interferon alpha (IFN-α) adjuvant therapy of melanoma patients and implication on electrochemotherapy effectiveness has not been explored yet. Therefore, the...

Cite
Hribernik A, Cemazar M, Sersa G, et al. Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients. Radiol Oncol. 2016;50(1):21-7doi: 10.1515/raon-2015-0048.
Hribernik, A., Cemazar, M., Sersa, G., Bosnjak, M., & Snoj, M. (2016). Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients. Radiology and oncology, 50(1), 21-7. https://doi.org/10.1515/raon-2015-0048
Hribernik, Andrejc, et al. "Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients." Radiology and oncology vol. 50,1 (2016): 21-7. doi: https://doi.org/10.1515/raon-2015-0048
Hribernik A, Cemazar M, Sersa G, Bosnjak M, Snoj M. Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients. Radiol Oncol. 2016 Feb 16;50(1):21-7. doi: 10.1515/raon-2015-0048. eCollection 2016 Mar 01. PMID: 27069446; PMCID: PMC4825333.
Copy Download .nbib Format: NLM
Intralesional Sclerotherapy - A Novel Approach for The Treatment of Intraoral Haemangiomas.

Journal of clinical and diagnostic research : JCDR

Reddy GS, Reddy GV, Reddy KS, Priyadarshini BS, Sree PK.
PMID: 26894188
J Clin Diagn Res. 2016 Jan;10(1):ZD13-4. doi: 10.7860/JCDR/2016/17568.7137. Epub 2016 Jan 01.

In infancy and childhood haemangiomas are the most common neoplasms in head and neck region with an occurrence of about 60%. Approximately 40%-50% of all haemangiomas resolve incompletely, leaving permanent changes in the skin, such as telangiectases, epidermal atrophy,...

Cite
Reddy GS, Reddy GV, Reddy KS, et al. Intralesional Sclerotherapy - A Novel Approach for The Treatment of Intraoral Haemangiomas. J Clin Diagn Res. 2016;10(1):ZD13-4doi: 10.7860/JCDR/2016/17568.7137.
Reddy, G. S., Reddy, G. V., Reddy, K. S., Priyadarshini, B. S., & Sree, P. K. (2016). Intralesional Sclerotherapy - A Novel Approach for The Treatment of Intraoral Haemangiomas. Journal of clinical and diagnostic research : JCDR, 10(1), ZD13-4. https://doi.org/10.7860/JCDR/2016/17568.7137
Reddy, G Siva Prasad, et al. "Intralesional Sclerotherapy - A Novel Approach for The Treatment of Intraoral Haemangiomas." Journal of clinical and diagnostic research : JCDR vol. 10,1 (2016): ZD13-4. doi: https://doi.org/10.7860/JCDR/2016/17568.7137
Reddy GS, Reddy GV, Reddy KS, Priyadarshini BS, Sree PK. Intralesional Sclerotherapy - A Novel Approach for The Treatment of Intraoral Haemangiomas. J Clin Diagn Res. 2016 Jan;10(1):ZD13-4. doi: 10.7860/JCDR/2016/17568.7137. Epub 2016 Jan 01. PMID: 26894188; PMCID: PMC4740717.
Copy Download .nbib Format: NLM
Neuroplastic Effects of Transcranial Direct Current Stimulation on Painful Symptoms Reduction in Chronic Hepatitis C: A Phase II Randomized, Double Blind, Sham Controlled Trial.

Frontiers in neuroscience

Brietzke AP, Rozisky JR, Dussan-Sarria JA, Deitos A, Laste G, Hoppe PF, Muller S, Torres IL, Alvares-da-Silva MR, de Amorim RF, Fregni F, Caumo W.
PMID: 26793047
Front Neurosci. 2016 Jan 11;9:498. doi: 10.3389/fnins.2015.00498. eCollection 2015.

INTRODUCTION: Pegylated Interferon Alpha (Peg-IFN) in combination with other drugs is the standard treatment for chronic hepatitis C infection (HCV) and is related to severe painful symptoms. The aim of this study was access the efficacy of transcranial direct...

Cite
Brietzke AP, Rozisky JR, Dussan-Sarria JA, et al. Neuroplastic Effects of Transcranial Direct Current Stimulation on Painful Symptoms Reduction in Chronic Hepatitis C: A Phase II Randomized, Double Blind, Sham Controlled Trial. Front Neurosci. 2016;9:498doi: 10.3389/fnins.2015.00498.
Brietzke, A. P., Rozisky, J. R., Dussan-Sarria, J. A., Deitos, A., Laste, G., Hoppe, P. F., Muller, S., Torres, I. L., Alvares-da-Silva, M. R., de Amorim, R. F., Fregni, F., & Caumo, W. (2015). Neuroplastic Effects of Transcranial Direct Current Stimulation on Painful Symptoms Reduction in Chronic Hepatitis C: A Phase II Randomized, Double Blind, Sham Controlled Trial. Frontiers in neuroscience, 9498. https://doi.org/10.3389/fnins.2015.00498
Brietzke, Aline P, et al. "Neuroplastic Effects of Transcranial Direct Current Stimulation on Painful Symptoms Reduction in Chronic Hepatitis C: A Phase II Randomized, Double Blind, Sham Controlled Trial." Frontiers in neuroscience vol. 9 (2015): 498. doi: https://doi.org/10.3389/fnins.2015.00498
Brietzke AP, Rozisky JR, Dussan-Sarria JA, Deitos A, Laste G, Hoppe PF, Muller S, Torres IL, Alvares-da-Silva MR, de Amorim RF, Fregni F, Caumo W. Neuroplastic Effects of Transcranial Direct Current Stimulation on Painful Symptoms Reduction in Chronic Hepatitis C: A Phase II Randomized, Double Blind, Sham Controlled Trial. Front Neurosci. 2016 Jan 11;9:498. doi: 10.3389/fnins.2015.00498. eCollection 2015. PMID: 26793047; PMCID: PMC4707227.
Copy Download .nbib Format: NLM
Giant cell tumor of bone revisited.

SICOT-J

Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, Panagopoulos GN, Papagelopoulos PJ, Soucacos PN.
PMID: 28905737
SICOT J. 2017;3:54. doi: 10.1051/sicotj/2017041. Epub 2017 Sep 14.

Giant cell tumor (GCT) of bone is a locally aggressive benign neoplasm that is associated with a large biological spectrum ranging from latent benign to highly recurrent and occasionally metastatic malignant bone tumor. It accounts for 4-10% of all...

Cite
Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, et al. Giant cell tumor of bone revisited. SICOT J. 2017;3:54doi: 10.1051/sicotj/2017041.
Mavrogenis, A. F., Igoumenou, V. G., Megaloikonomos, P. D., Panagopoulos, G. N., Papagelopoulos, P. J., & Soucacos, P. N. (2017). Giant cell tumor of bone revisited. SICOT-J, 354. https://doi.org/10.1051/sicotj/2017041
Mavrogenis, Andreas F, et al. "Giant cell tumor of bone revisited." SICOT-J vol. 3 (2017): 54. doi: https://doi.org/10.1051/sicotj/2017041
Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, Panagopoulos GN, Papagelopoulos PJ, Soucacos PN. Giant cell tumor of bone revisited. SICOT J. 2017;3:54. doi: 10.1051/sicotj/2017041. Epub 2017 Sep 14. PMID: 28905737; PMCID: PMC5598212.
Copy Download .nbib Format: NLM
Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra.

Kidney research and clinical practice

Podestà MA, Graziani G, Reggiani F, Buemi M, Badalamenti S, Ponticelli C.
PMID: 26877969
Kidney Res Clin Pract. 2014 Sep;33(3):165-7. doi: 10.1016/j.krcp.2014.07.007. Epub 2014 Sep 10.

Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by infiltrates of lipid-laden CD68(+)/CD1a(-) histiocytes, affecting heart, lungs, central nervous system, and bones. Kidney and adjacent structures can also be affected, leading to renal failure in about 30%...

Cite
Podestà MA, Graziani G, Reggiani F, et al. Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra. Kidney Res Clin Pract. 2014;33(3):165-7doi: 10.1016/j.krcp.2014.07.007.
Podestà, M. A., Graziani, G., Reggiani, F., Buemi, M., Badalamenti, S., & Ponticelli, C. (2014). Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra. Kidney research and clinical practice, 33(3), 165-7. https://doi.org/10.1016/j.krcp.2014.07.007
Podestà, Manuel Alfredo, et al. "Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra." Kidney research and clinical practice vol. 33,3 (2014): 165-7. doi: https://doi.org/10.1016/j.krcp.2014.07.007
Podestà MA, Graziani G, Reggiani F, Buemi M, Badalamenti S, Ponticelli C. Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra. Kidney Res Clin Pract. 2014 Sep;33(3):165-7. doi: 10.1016/j.krcp.2014.07.007. Epub 2014 Sep 10. PMID: 26877969; PMCID: PMC4714171.
Copy Download .nbib Format: NLM
Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management.

Hematology (Amsterdam, Netherlands)

Ravandi-Kashani F, Cortes J, Kantarjian H, Talpaz M.
PMID: 27413879
Hematology. 1998;3(4):263-76. doi: 10.1080/10245332.1998.11746399.

Over the past two decades advances in the understanding of molecular and biological aspects of chronic myeloid leukemia (CML) have served as one of the cornerstones of progress in the management of leukemias, and more broadly of cancer in...

Cite
Ravandi-Kashani F, Cortes J, Kantarjian H, et al. Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management. Hematology. 1998;3(4):263-76doi: 10.1080/10245332.1998.11746399.
Ravandi-Kashani, F., Cortes, J., Kantarjian, H., & Talpaz, M. (1998). Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management. Hematology (Amsterdam, Netherlands), 3(4), 263-76. https://doi.org/10.1080/10245332.1998.11746399
Ravandi-Kashani, F, et al. "Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management." Hematology (Amsterdam, Netherlands) vol. 3,4 (1998): 263-76. doi: https://doi.org/10.1080/10245332.1998.11746399
Ravandi-Kashani F, Cortes J, Kantarjian H, Talpaz M. Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management. Hematology. 1998;3(4):263-76. doi: 10.1080/10245332.1998.11746399. PMID: 27413879.
Copy Download .nbib Format: NLM
Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1.

Hepatitis monthly

Sharafi H, Alavian SM, Keshvari M.
PMID: 25741374
Hepat Mon. 2015 Jan 01;15(1):e24955. doi: 10.5812/hepatmon.24955. eCollection 2015 Jan.

BACKGROUND: Previous studies using pegylated interferon (Peg-IFN) and ribavirin (RBV) combination therapy suggested that patients with hepatitis C virus (HCV) genotype 1 and low pretreatment HCV RNA level who achieved rapid virological response (RVR) can be treated for 24...

Cite
Sharafi H, Alavian SM, Keshvari M. Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1. Hepat Mon. 2015;15(1):e24955doi: 10.5812/hepatmon.24955.
Sharafi, H., Alavian, S. M., & Keshvari, M. (2015). Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1. Hepatitis monthly, 15(1), e24955. https://doi.org/10.5812/hepatmon.24955
Sharafi, Heidar, et al. "Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1." Hepatitis monthly vol. 15,1 (2015): e24955. doi: https://doi.org/10.5812/hepatmon.24955
Sharafi H, Alavian SM, Keshvari M. Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1. Hepat Mon. 2015 Jan 01;15(1):e24955. doi: 10.5812/hepatmon.24955. eCollection 2015 Jan. PMID: 25741374; PMCID: PMC4330713.
Copy Download .nbib Format: NLM
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera.

Leukemia & lymphoma

Utke Rank C, Weis Bjerrum O, Larsen TS, Kjær L, de Stricker K, Riley CH, Hasselbalch HC.
PMID: 25956046
Leuk Lymphoma. 2016 Feb;57(2):348-354. doi: 10.3109/10428194.2015.1049171. Epub 2015 Jun 18.

Essential thrombocythemia (ET) and polycythemia vera (PV) are Philadelphia chromosome-negative chronic myeloproliferative neoplasms (MPNs) characterized by the JAK2 V617F mutation, which can be found in more than 98% of PV patients and in ∼ 50% of ET patients. Assessment...

Cite
Utke Rank C, Weis Bjerrum O, Larsen TS, et al. Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera. Leuk Lymphoma. 2015;57(2):348-354doi: 10.3109/10428194.2015.1049171.
Utke Rank, C., Weis Bjerrum, O., Larsen, T. S., Kjær, L., de Stricker, K., Riley, C. H., & Hasselbalch, H. C. (2016). Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera. Leukemia & lymphoma, 57(2), 348-354. https://doi.org/10.3109/10428194.2015.1049171
Utke Rank, Cecilie, et al. "Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera." Leukemia & lymphoma vol. 57,2 (2016): 348-354. doi: https://doi.org/10.3109/10428194.2015.1049171
Utke Rank C, Weis Bjerrum O, Larsen TS, Kjær L, de Stricker K, Riley CH, Hasselbalch HC. Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera. Leuk Lymphoma. 2016 Feb;57(2):348-354. doi: 10.3109/10428194.2015.1049171. Epub 2015 Jun 18. PMID: 25956046.
Copy Download .nbib Format: NLM
Bell's palsy during interferon alpha 2a treatment in a case with Behçet uveitis.

F1000Research

Yalçindağ FN, Alay C.
PMID: 24715961
F1000Res. 2013 Nov 15;2:245. doi: 10.12688/f1000research.2-245.v1. eCollection 2013.

PURPOSE: To present a case who developed Bell's palsy while using interferon alpha 2a for Behçet uveitis.METHODS: A patient with Behçet disease presented with decreased vision in his right eye. Ophthalmic examination, fundus fluorescein angiography and optical coherence tomography...

Cite
Yalçindağ FN, Alay C. Bell's palsy during interferon alpha 2a treatment in a case with Behçet uveitis. F1000Res. 2013;2:245doi: 10.12688/f1000research.2-245.v1.
Yalçindağ, F. N., & Alay, C. (2013). Bell's palsy during interferon alpha 2a treatment in a case with Behçet uveitis. F1000Research, 2245. https://doi.org/10.12688/f1000research.2-245.v1
Yalçindağ, Fatime Nilüfer, and Alay, Cem. "Bell's palsy during interferon alpha 2a treatment in a case with Behçet uveitis." F1000Research vol. 2 (2013): 245. doi: https://doi.org/10.12688/f1000research.2-245.v1
Yalçindağ FN, Alay C. Bell's palsy during interferon alpha 2a treatment in a case with Behçet uveitis. F1000Res. 2013 Nov 15;2:245. doi: 10.12688/f1000research.2-245.v1. eCollection 2013. PMID: 24715961; PMCID: PMC3962000.
Copy Download .nbib Format: NLM
An Exploration of Depressive Symptoms in Hepatitis C Patients Taking Interferon-alpha: Increase in Sickness Behaviors but not Negative Cognitions.

Journal of clinical and experimental hepatology

Smith KJ, Norris S, McKiernan S, Hynes B, O'Dwyer AM, O'Mara SM.
PMID: 25755437
J Clin Exp Hepatol. 2012 Sep;2(3):218-23. doi: 10.1016/j.jceh.2012.03.001. Epub 2012 Sep 21.

OBJECTIVE: The most investigated adverse event associated with interferon-alpha (IFN-α) treatment is depressed mood, with many studies finding a significant increase in depression scale scores from baseline to treatment. This paper is concerned with exploring discrete categories of depressive...

Cite
Smith KJ, Norris S, McKiernan S, et al. An Exploration of Depressive Symptoms in Hepatitis C Patients Taking Interferon-alpha: Increase in Sickness Behaviors but not Negative Cognitions. J Clin Exp Hepatol. 2012;2(3):218-23doi: 10.1016/j.jceh.2012.03.001.
Smith, K. J., Norris, S., McKiernan, S., Hynes, B., O'Dwyer, A. M., & O'Mara, S. M. (2012). An Exploration of Depressive Symptoms in Hepatitis C Patients Taking Interferon-alpha: Increase in Sickness Behaviors but not Negative Cognitions. Journal of clinical and experimental hepatology, 2(3), 218-23. https://doi.org/10.1016/j.jceh.2012.03.001
Smith, Kimberley J, et al. "An Exploration of Depressive Symptoms in Hepatitis C Patients Taking Interferon-alpha: Increase in Sickness Behaviors but not Negative Cognitions." Journal of clinical and experimental hepatology vol. 2,3 (2012): 218-23. doi: https://doi.org/10.1016/j.jceh.2012.03.001
Smith KJ, Norris S, McKiernan S, Hynes B, O'Dwyer AM, O'Mara SM. An Exploration of Depressive Symptoms in Hepatitis C Patients Taking Interferon-alpha: Increase in Sickness Behaviors but not Negative Cognitions. J Clin Exp Hepatol. 2012 Sep;2(3):218-23. doi: 10.1016/j.jceh.2012.03.001. Epub 2012 Sep 21. PMID: 25755437; PMCID: PMC3940096.
Copy Download .nbib Format: NLM
Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China.

International journal of clinical and experimental medicine

Nan YM, Zhang YG, Zheng HW, An CM, Li YS, Zhang Y, Sun DX, Li CY, Li Q, Tong LX, Kong LB, Zhao SX, Wang RQ, Meng P, Su SS, He H, Niu XM.
PMID: 26628969
Int J Clin Exp Med. 2015 Sep 15;8(9):14871-84. eCollection 2015.

Combination therapy comprising pegylated interferon-alpha (PegIFNα) and ribavirin (RBV) has been the standard of care for the chronic hepatitis C patients for more than a decade. Recently, direct antiviral agents show better efficacy, tolerance, and shorter treatment duration. However,...

Cite
Nan YM, Zhang YG, Zheng HW, et al. Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China. Int J Clin Exp Med. 2015;8(9):14871-84
Nan, Y. M., Zhang, Y. G., Zheng, H. W., An, C. M., Li, Y. S., Zhang, Y., Sun, D. X., Li, C. Y., Li, Q., Tong, L. X., Kong, L. B., Zhao, S. X., Wang, R. Q., Meng, P., Su, S. S., He, H., & Niu, X. M. (2015). Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China. International journal of clinical and experimental medicine, 8(9), 14871-84.
Nan, Yue-Min, et al. "Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China." International journal of clinical and experimental medicine vol. 8,9 (2015): 14871-84.
Nan YM, Zhang YG, Zheng HW, An CM, Li YS, Zhang Y, Sun DX, Li CY, Li Q, Tong LX, Kong LB, Zhao SX, Wang RQ, Meng P, Su SS, He H, Niu XM. Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China. Int J Clin Exp Med. 2015 Sep 15;8(9):14871-84. eCollection 2015. PMID: 26628969; PMCID: PMC4658858.
Copy Download .nbib Format: NLM
Alpha interferon for hepatitis C virus infection in haemophilic patients.

Haemophilia : the official journal of the World Federation of Hemophilia

Telfer P, Devereux H, Colvin B, Hayden S, Dusheiko G, Lee C.
PMID: 27214222
Haemophilia. 1995 Jan;1(1):54-8. doi: 10.1111/j.1365-2516.1995.tb00040.x.

We have conducted a controlled trial in 20 haemophilic patients in which intravenous recombinant interferon alpha-2a, 3 mega units thrice weekly, was used to treat chronic hepatitis C infection. The study endpoints included complete and paritial normalization of serum...

Cite
Telfer P, Devereux H, Colvin B, et al. Alpha interferon for hepatitis C virus infection in haemophilic patients. Haemophilia. 1995;1(1):54-8doi: 10.1111/j.1365-2516.1995.tb00040.x.
Telfer, P., Devereux, H., Colvin, B., Hayden, S., Dusheiko, G., & Lee, C. (1995). Alpha interferon for hepatitis C virus infection in haemophilic patients. Haemophilia : the official journal of the World Federation of Hemophilia, 1(1), 54-8. https://doi.org/10.1111/j.1365-2516.1995.tb00040.x
Telfer, P, et al. "Alpha interferon for hepatitis C virus infection in haemophilic patients." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,1 (1995): 54-8. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00040.x
Telfer P, Devereux H, Colvin B, Hayden S, Dusheiko G, Lee C. Alpha interferon for hepatitis C virus infection in haemophilic patients. Haemophilia. 1995 Jan;1(1):54-8. doi: 10.1111/j.1365-2516.1995.tb00040.x. PMID: 27214222.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 848 entries